Katalin Váradi

2.3k total citations
55 papers, 1.8k citations indexed

About

Katalin Váradi is a scholar working on Hematology, Genetics and Surgery. According to data from OpenAlex, Katalin Váradi has authored 55 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Hematology, 12 papers in Genetics and 9 papers in Surgery. Recurrent topics in Katalin Váradi's work include Blood Coagulation and Thrombosis Mechanisms (31 papers), Hemophilia Treatment and Research (31 papers) and Platelet Disorders and Treatments (19 papers). Katalin Váradi is often cited by papers focused on Blood Coagulation and Thrombosis Mechanisms (31 papers), Hemophilia Treatment and Research (31 papers) and Platelet Disorders and Treatments (19 papers). Katalin Váradi collaborates with scholars based in Austria, Hungary and Netherlands. Katalin Váradi's co-authors include Peter L. Turecek, H. P. Schwarz, Hans Peter Schwarz, Jan Rosing, Guido Tans, H.C. Hemker, Gerry A. F. Nicolaes, Stella Thomassen, Herbert Gritsch and Paul Knöbl and has published in prestigious journals such as Journal of Biological Chemistry, Blood and Critical Care Medicine.

In The Last Decade

Katalin Váradi

51 papers receiving 1.7k citations

Peers

Katalin Váradi
Jan Roodt South Africa
Dipika Mohanty India
Martine J. Hollestelle Netherlands
María Fernanda López Fernández Spain
Ralph Vassallo United States
Tor Henrik Anderson Tvedt Norway
Nicholas Wickham Australia
Behnaz Parhami-Seren United States
Richard H. Aster United States
M. A. Boogaerts Belgium
Jan Roodt South Africa
Katalin Váradi
Citations per year, relative to Katalin Váradi Katalin Váradi (= 1×) peers Jan Roodt

Countries citing papers authored by Katalin Váradi

Since Specialization
Citations

This map shows the geographic impact of Katalin Váradi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katalin Váradi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katalin Váradi more than expected).

Fields of papers citing papers by Katalin Váradi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katalin Váradi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katalin Váradi. The network helps show where Katalin Váradi may publish in the future.

Co-authorship network of co-authors of Katalin Váradi

This figure shows the co-authorship network connecting the top 25 collaborators of Katalin Váradi. A scholar is included among the top collaborators of Katalin Váradi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katalin Váradi. Katalin Váradi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zeerleder, Sacha, Femke Stephan, Marieke Emonts, et al.. (2012). Circulating nucleosomes and severity of illness in children suffering from meningococcal sepsis treated with protein C. Critical Care Medicine. 40(12). 3224–3229. 51 indexed citations
2.
Turecek, Peter L., M.J. Bossard, Michael Graninger, et al.. (2012). BAX 855, a PEGylated rFVIII product with prolonged half-life. Development, functional and structural characterisation.. PubMed. 32 Suppl 1. S29–38. 86 indexed citations
3.
Turecek, Peter L., Gerald Schrenk, Hanspeter Rottensteiner, et al.. (2010). Structure and Function of a Recombinant von Willebrand Factor Drug Candidate. Seminars in Thrombosis and Hemostasis. 36(5). 510–521. 43 indexed citations
4.
Váradi, Katalin, Hanspeter Rottensteiner, Susanne Vejda, et al.. (2009). Species‐dependent variability of ADAMTS13‐mediated proteolysis of human recombinant von Willebrand factor. Journal of Thrombosis and Haemostasis. 7(7). 1134–1142. 16 indexed citations
5.
Tripodi, Armando, Flora Peyvandi, Veena Chantarangkul, et al.. (2008). Second international collaborative study evaluating performance characteristics of methods measuring the von Willebrand factor cleaving protease (ADAMTS‐13). Journal of Thrombosis and Haemostasis. 6(9). 1534–1541. 38 indexed citations
6.
Turecek, Peter L., Artur Mitterer, Herbert Gritsch, et al.. (2006). Biochemical and Functional Characterization of a Serum-Free rVWF Drug Candidate.. Blood. 108(11). 1017–1017. 2 indexed citations
7.
Spiel, Alexander, Christa Firbas, Florian Mayr, et al.. (2005). The effects of supra-normal protein C levels on markers of coagulation, fibrinolysis and inflammation in a human model of endotoxemia. Thrombosis and Haemostasis. 94(12). 1148–1156. 8 indexed citations
8.
Váradi, Katalin, Peter L. Turecek, & H. P. Schwarz. (2004). Thrombin generation assay and other universal tests for monitoring haemophilia therapy. Haemophilia. 10(s2). 17–21. 51 indexed citations
9.
Turecek, Peter L., Katalin Váradi, Herbert Gritsch, & H. P. Schwarz. (2004). FEIBA®: mode of action. Haemophilia. 10(s2). 3–9. 118 indexed citations
10.
Kerschbaumer, Randolf J., et al.. (2004). An Antibody Specific for Coagulation Factor IX Enhances the Activity of the Intrinsic Factor X-activating Complex. Journal of Biological Chemistry. 279(39). 40445–40450. 7 indexed citations
11.
Turecek, P. L., Katalin Váradi, B. Keil, et al.. (2003). Factor VIII Inhibitor-Bypassing Agents Act by Inducing Thrombin Generation and Can Be Monitored by a Thrombin Generation Assay. Pathophysiology of Haemostasis and Thrombosis. 33(1). 16–22. 98 indexed citations
12.
Schwarz, Hans Peter, Uwe Schlokat, Artur Mitterer, et al.. (2002). Recombinant von Willebrand Factor-Insight into Structure and Function through Infusion Studies in Animals with Severe von Willebrand Disease. Seminars in Thrombosis and Hemostasis. 28(2). 215–226. 12 indexed citations
13.
Turecek, Peter L., Katalin Váradi, Uwe Schlokat, et al.. (2002). In vivo and in vitro processing of recombinant pro-von Willebrand factor. Histochemistry and Cell Biology. 117(2). 123–129. 8 indexed citations
14.
Turecek, Peter L., Katalin Váradi, Herbert Gritsch, et al.. (1999). Factor Xa and Prothrombin: Mechanism of Action of FEIBA. Vox Sanguinis. 77(S1). 72–79.
15.
Turecek, Peter L., Katalin Váradi, Herbert Gritsch, et al.. (1999). Factor Xa and Prothrombin: Mechanism of Action of FEIBA. Vox Sanguinis. 77(Suppl. 1). 72–79. 48 indexed citations
16.
Mustafa, Stefan, Ingrid Pabinger, Katalin Váradi, et al.. (1997). A hitherto unknown splice site defect in the protein S gene (PROS1): the mutation results in allelic exclusion and causes type I and type III protein S deficiency. British Journal of Haematology. 99(2). 298–300. 7 indexed citations
17.
Nicolaes, Gerry A. F., Guido Tans, Stella Thomassen, et al.. (1995). Peptide Bond Cleavages and Loss of Functional Activity during Inactivation of Factor Va and Factor VaR506Q by Activated Protein C. Journal of Biological Chemistry. 270(36). 21158–21166. 203 indexed citations
18.
Rosing, Jan, Lico Hoekema, Gerry A. F. Nicolaes, et al.. (1995). Effects of Protein S and Factor Xa on Peptide Bond Cleavages during Inactivation of Factor Va and Factor VaR506Q by Activated Protein C. Journal of Biological Chemistry. 270(46). 27852–27858. 193 indexed citations
19.
Pichler, Ludwig, W Schramm, Ulrich Walter, Katalin Váradi, & Hans‐Peter Schwarz. (1995). Antinociceptive Properties of Protein C in a Model of Inflammatory Hyperalgesia in Rats. Thrombosis and Haemostasis. 73(2). 252–255. 4 indexed citations
20.
Váradi, Katalin, et al.. (1978). Some Sources of Error in the One-Stage Assay of Factor VIII. Pathophysiology of Haemostasis and Thrombosis. 7(1). 1–9. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jan Roodt Breakdown of academic impact, for papers by Dipika Mohanty Breakdown of academic impact, for papers by Martine J. Hollestelle Breakdown of academic impact, for papers by María Fernanda López Fernández Breakdown of academic impact, for papers by Ralph Vassallo Breakdown of academic impact, for papers by Tor Henrik Anderson Tvedt Breakdown of academic impact, for papers by Nicholas Wickham Breakdown of academic impact, for papers by Behnaz Parhami-Seren Breakdown of academic impact, for papers by Richard H. Aster Breakdown of academic impact, for papers by M. A. Boogaerts
Rankless by CCL
2026